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Background: There is increased research interest in the use of mobile phone apps to support diabetes management. However,
there are divergent views on what constitute the minimum standards for inclusion in the development of mobile phone apps.
Mobile phone apps require an evidence-based approach to development which will consequently impact on their effectiveness.
Therefore, comprehensive information on developmental considerations could help designers and researchers to develop innovative
and effective patient-centered self-management mobile phone apps for diabetes patients.
Objective: This systematic review examined the developmental considerations adopted in trials that engaged mobile phone
applications for diabetes self-management.
Methods: A comprehensive search strategy was implemented across 5 electronic databases; Medline, Scopus, Social Science
Citation Index, the Cochrane Central Register of Controlled Trials and Cumulative Index of Nursing and Allied Health Literature
(CINALHL) and supplemented by reference list from identified studies. Study quality was evaluated using the Joanna Briggs
Critical appraisal checklist for trials. Information on developmental factors (health behavioral theory, functionality, pilot testing,
user and clinical expert involvements, data privacy and app security) were assessed across experimental studies using a template
developed for the review.
Results: A total of 11 studies (10 randomized controlled trials and 1 quasi-experimental trial) that fitted the inclusion criteria
were identified. All the included studies had the functionality of self-monitoring of blood glucose. However, only some of them
included functions for data analytics (7/11, 63.6%), education (6/11, 54.5%) and reminder (6/11, 54.5%). There were 5/11(45.5%)
studies with significantly improved glycosylated hemoglobin in the intervention groups where educational functionality was
present in the apps used in the 5 trials. Only 1 (1/11, 9.1%) study considered health behavioral theory and user involvement, while
2 (2/11, 18.1%) other studies reported the involvement of clinical experts in the development of their apps. There were 4 (4/11,
36.4%) studies which referred to data security and privacy considerations during their app development while 7 (7/12, 63.6%)
studies provided information on pilot testing of apps before use in the full trial. Overall, none of the studies provided information
on all developmental factors assessed in the review.
Conclusions: There is a lack of elaborate and detailed information in the literature regarding the factors considered in the
development of apps used as interventions for diabetes self-management. Documentation and inclusion of such vital information
will foster a transparent and shared decision-making process that will ultimately lead to the development of practical and
user-friendly self-management apps that can enhance the quality of life for diabetes patients.
(JMIR Mhealth Uhealth 2018;6(6):e10115)   doi:10.2196/10115
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Introduction
Background
Mobile apps refer to software installed on smart mobile devices
that support medical and public health practices [1]. These apps
can deliver health care anywhere, subduing geographical and
organizational barriers as well as time constraints [2,3]. Their
intended use is for diagnosis, self-management, mitigation,
treatment or prevention of diseases such as diabetes [4].
Self-management of blood glucose minimizes the risk and health
complications associated with the insidious and chronic nature
of diabetes [5,6]. Diabetes self-management includes monitoring
of glucose level, lifestyle modifications, medication
management, prevention of complications and psychosocial
care [7]. As a standard, diabetes self-management education is
usually provided during outpatient visits; but it has been
advocated that most patients require ongoing support to
encourage and sustain behavior at the level that can maintain
good health [8,9]. Hence, the necessity for a regularly accessible
form of diabetes self-management education and support; which
can be achieved with the use of mobile apps.
Although, mobile apps are a field that has continually attracted
the interest of researchers and has excellent prospects, both for
the improvement of health care and economic interest [10,11],
comprehensive information on its developmental considerations
seem somewhat limited. Studies have reported gaps in the
understanding of formal standards and evidence-based
approaches employed in the development and evaluation of the
effectiveness of mobile apps [12,13].
Considerations in Mobile Phone App Development
Presently, knowledge about the standard recommended practice
for mobile app development for chronic disease management
seems divergent and inconclusive. Some studies have reported
the benefits of developing mobile apps based on health behavior
and communication change theories [14,15]. The main reason
for using these theories is to adopt techniques and strategies
and help patients embrace healthier lifestyles. Existing models
and theories include transtheoretical model [16], social cognitive
theory [17], self-determination theory [18], social ecological
theory [17] and motivational interviewing [19]. These theories
have served as guards in designing mobile app interventions to
individuals’ baseline characteristics.
Some authors are of the opinion that the development of health
care tools for patient groups such as those with diabetes requires
an understanding of current challenges and barriers to self-care
[20]. This approach serves as an avenue for exploring users’
needs at a specific time and envisaging what may evolve with
time. This can help in visualizing the use of the app as users’
demands change [21,22].
Chomutare et al [23] emphasized in their systematic review that
good practice in designing mobile apps requires that inclusion
of functionalities be anchored on evidence-based
recommendations for the target groups. Furthermore, pilot
testing with a target audience and incorporating feedbacks will
aid identification of barriers to the usage of mobile apps and
enhance the evaluation of its reliability, accuracy, usability,
acceptability, and patient adherence [3]. Ensuring the
incorporation of evidence-based recommendations and pilot
testing into app development for diabetes care will allow for
accurate interfaces, interpretations, and evaluation of the
effectiveness of the mobile app.
Data privacy and security whereby the users’ information is
securely managed is another major developmental consideration
[3,24]. Emphasising the use of ‘privacy by design’ approach
such as encryption and protocols for anonymous communication
and authentication helps to deter unauthorized users from
gaining access to patients’ medical data [25,26]. Furthermore,
it has been recommended that involvement of clinical experts
and multidisciplinary health teams should be an integral part of
the developmental and testing process of diabetes mobile apps
to ensure that medical guidelines and clinical best practices are
followed in the management of diabetes [27].
The various views described above can be labeled as shared
decision-making approach to the development of mobile app.
Diabetes care and support using this approach in which patients,
health care providers, and app developers make health care
decision together; taking into account specific evidence as well
as specific needs and preferences of patients, has been
recommended by various studies because it is seen to produce
effective health outcomes [28-30]. Such an approach focuses
on patient empowerment, ensuring a transition from a state
where patients are only seen as the recipients of care to a
position where they also have their opinion considered, and they
are allowed to make choices, thereby actively contributing to
the decision-making process. Given that the organizational
structure within the health care sector now recognizes the
patients’ greater role in their health care, this trend should also
result in a shift in the process involved in the development of
mobile apps. Patient engagement strategies in app development
may not necessarily refer to their involvement in the algorithm
design but rather in the incorporation of procedures that meet
patients’ expectations through the consideration of their
experiences, needs, reasons for engagement and satisfaction
with the usage of the app.
Mobile apps have been proven to be a useful lifestyle
modification tool for providing ongoing individual self-care
support for diabetes management and facilitating regular
monitoring for improved health outcomes [31-36]. However,
previous reviews have focused mainly on assessing the
effectiveness of mobile apps to support diabetes
self-management [11,33,34,36,37]. A mixture of shared
decision-making approaches that include developmental
considerations such as health behavioral theories, user and
clinical expert involvement, pilot testing and data security are
essential to help solve the problems of poor engagement
experience and ineffective use of mobile apps [38].
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The inclusion of robust, reliable and repeatable system design
that involves end users early in the developmental consideration
process will enhance ongoing support which is crucial to
sustaining progress made by diabetes patients in their
self-management [39]. To the best of our knowledge, no other
study has collated evidence on the factors taken into
consideration in the development of such apps. This evidence
will further aid the advancement of evidence-based development
and evaluation of mobile apps for effective diabetes
management.
This systematic review aims to evaluate the factors taken into
consideration in the development of mobile phone-based apps
used as self-management interventions in experimental trials of
adults with diabetes. Also, the review compares these mobile
app developmental factors with their impact on the key clinical
outcome variable glycosylated hemoglobin (HbA1c). For this
study, the developmental factors considered are categorized into
the following: (1) Health behavioural change theory, (2)
Function/Functionality (comprising documentation, analytics,
reminder, and education), (3) Users involvement, (4) Clinical
expert involvement, (5) Data security and privacy consideration,
and (6) Pilot testing. These factors were considered based on
extensive literature search and ingeminate brainstorming
sessions among co-authors, with a focus to provide a guide on
factors to consider in the development process of mobile app
for diabetes self-management precluding the use of such apps
in a full trial.
Methods
This systematic review was conducted following the Preferred
Reporting Items for Systematic Review and Meta-Analyses
(PRISMA) statement [40]. Assessed developmental
considerations are based solely on author reported descriptions
directly available in the selected studies or referenced in another
published article. For this review, we defined mobile phone
apps as apps that are downloadable to mobile phones and take
data inputs from users with a focus on improving one or more
aspects of diabetes self-management domains.
Data Sources and Search Strategy
Published literature sources were identified by searching
Medline, Cumulative Index to Nursing and Allied Health
Literature (CINAHL, EBSCOhost), Scopus, Social Science
Citation Index and Cochrane Register of Controlled Trials
(CENTRAL) databases. In order for search results to have the
maximum possible coverage, the combination of the following
terms and medical subject headings were used during the search:
(‘‘Type 1 diabetes mellitus’’ OR ‘‘Type 2 diabetes mellitus’’
OR diabet* OR IDDM OR NIDDM) AND (‘‘Mobile
applications’’ OR , Smartphone* OR ‘‘app’’ OR ‘‘cellular
phone’’ OR ‘‘mobile app’’ OR ‘‘portable electronic
applications’’ OR ‘‘portable software application’’ OR ‘‘text
messages’’). Searches were done between 5th-29thSeptember
2017. Searches were supplemented by manual searching of
reference lists of identified studies.
Selection Criteria
Selected studies were any randomized controlled trial (RCT),
quasi-experimental study, or pre-post study evaluating the use
of mobile apps for self-management in patients (≥ 18 years)
with type 1 or 2 diabetes. Studies included were those that used
mobile phone-based app intervention which allows real-time
interaction between patients and the software. Such interactions
include input from the user (which may or may not allow for
reinforcement of personalized or general advice), goal setting,
data analytics, decision support or reminders to improve diabetes
self-management. Strict inclusion criteria were applied to
streamline and capture only diabetes interventional studies.
Therefore, to ensure review of fully functional apps used as an
intervention for diabetes management, only trials that evaluated
at least one glycemia index of glycosylated hemoglobin (HbA1c)
or blood glucose levels as primary outcome were included.
Selected studies were those published in the English language
but not restricted to patients of any particular race.
Exclusion criteria included: (1) technological interventions not
including mobile phone based app, for example systems which
require patients to input data into a Web-based server for review
by clinician or researcher, (2) systematic reviews, meta-analyses,
conference papers or letters, (3) pre-diabetes, gestational and
secondary diabetes, (4) obesity, (5) software solutions mainly
for insulin pumps only, (6) studies on mixed populations of
adults and children, and (7) studies still ongoing that presented
interim results only.
Data Extraction
The titles and abstracts of all identified references were reviewed
by the first author (MD). References that did not meet all of the
inclusion criteria were excluded. The full-text article of all
relevant references was retrieved and assessed. Data were
extracted from each selected studies using an electronic form
purposely developed for this review. All authors checked the
extracted data for consistency. Discrepancies were resolved
through discussion.
Quality Assessment
Assessment of study quality was performed by one author (MD)
in consultation with a second author (BMA). The quality was
evaluated using Joanna Briggs Institute’s pre-designed
standardized critical appraisal tools [41]. For the RCTs the
following criteria were considered: (1) true randomization of
assignments, (2) allocation concealment, (3) blinding of outcome
assessors, (4) intention-to-treat analysis, and (5) appropriateness
of trial design. Criteria considered for the quasi-experimental
trial included (1) clear description of cause and effect, (2)
presence of a control group, and (3) pre and post intervention
outcome measurements were assessed. For all studies, criteria
included (1) details of similarity in baseline characteristics, (2)
identical treatment for groups with the exception of intervention
of interest, (3) degree and description of follow up, (4)
similarities in group outcome measurements, (5) reliability of
outcome (primary outcome of HbA1c or blood glucose levels),
and (6) suitability of statistical analysis were evaluated. Blinding
of participants and personnel were part of the quality criteria in
the tools but were omitted and termed non-applicable since the
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nature of the intervention under study makes it difficult to
achieve blinding. All criteria on the tools were scored on a 2
point scale: Yes (1 point) or no or unclear (0 points). When
adding all quality criteria, the maximum obtainable scores was
11 for the RCTs and 9 for the quasi-controlled trials. Depending
on the number of criteria met by each study, the quality of each
study was graded as High (≥7 points), moderate (4-6 points) or




The initial search from the 5 databases identified 1203 articles
which included 116 duplicates that were removed. Based on
the review of the titles and abstracts, 53 articles were potentially
relevant. The full text of these articles was retrieved for further
examination, and their references were manually screened to
identify articles that were not included in the original search.
This process yielded 4 additional articles. After reading the full
articles, 12 studies met the set inclusion criteria. The studies by
Quinn et al [42,43] reported on the same study population, with
different group classifications. The studies by Rossi et al [44,45]
engaged the same app but in different study populations.
Therefore, 11 RCTs and 1 quasi-experimental study were
eventually included. An adapted PRISMA (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses) flow-chart
of study selection is shown in Figure 1.
Figure 1. Flow diagram of the study selection process.
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There were 7/12 (58.3%) true randomization trials [44-50], and
2/12 (16.7%)trials had unclear evidence for their randomization
method as there was insufficient detail to make a judgment
[42,43]. Allocation concealment was documented in only 1/12
(8.3%) study [48].
A total of 7/12 (58.3%) studies reported an intention-to-treat
analysis of their data [43-47,50,51]. There was 1/12 (8.3%)
study that reported the use of a linear mixed methodology which
allowed the inclusion of all randomized participants [48]. A
total of 9/12 (75.0%) studies had details of attrition with reasons
for drop out balanced across groups [42-46,48-50,52].
All studies had similar and reliable HbA1c measure. All studies,
except 1/12 (8.3%) by Istepanian et al [47], were judged to be
appropriate in their statistical analyses and trial designs. Overall,
10/12 (83.3%) studies were graded as high quality because they
met 7-9 criteria of the grading tool, 1/12 (8.3%) study met 6 of
the criteria and was graded as moderate [47], and the last study
(1/12, 8.3%) met only 2 quality criteria [53], was graded as poor
and removed from the review.
Characteristics of Included Studies
The 11 studies selected evaluated 9 mobile apps and were
published between 2009 and 2016. A total of 10/11 (91.1%)
studies were RCTs, while 1/11 (9.1%) was a quasi-experimental
study [52]. Participant numbers ranged from 54 [50] to 213
[43]. There were 4/11 (36.4%) studies which focused on type
1 diabetes [44-46,48], 6/11 (54.5%) studies were specific to
type 2 diabetes while 1/11 (9.1%) study [47] involved both type
1 and 2 diabetes patients. Intervention duration for 8/11 (72.7%)
studies ranged from 2 to 10 months, while the remaining 3/11
(27.3%) studies [42,43,51] had their follow up period extended
to 1 year. Study locations were from four geographic regions
including Europe (6/11, 54.5%), Oceania (1/11, 9.1%), Asia
(2/11, 18.2%) and America (2/11, 18.2%).
All studies had major interventions using a mobile app. A total
of 2/11 (18.2%) studies had 2 intervention groups [46,51] and
another 2 studies had 3 intervention groups [42,43].
HbA1c was the primary outcome measure in all trials. A total
of 5/11 (45.4%) studies reported a positive and statistically
significant improvement in HbA1c in the intervention group
[43,46,48-50]. A total of 5/11 (45.4%) studies had HbA1c
reduction in both the intervention and control groups
[42,44,45,51,52]. While in 1/11 (9.1%) study, HbA1c remained
unchanged between the intervention and control groups [47].
A summary of these characteristics is shown in Multimedia
Appendix 1.
Multimedia Appendix 2 and Multimedia Appendix 3 detail the
developmental factors considered in each of the reviewed studies
and the resulting key clinical outcome (HbA1c).
Health Behavioral Theories
Only 1/11 (9.1%) study [49] reported on health behavioral
theories. Specifically, motivation behavioural skills model was
used for the formulation of an automated personalised feedback
message content of the mobile app.
Functions of Mobile Apps
It was apparent from the review that functions of the mobile
apps were diverse. However, documentation for self-monitoring
of blood glucose (BG) either manually or through wireless
transmission from BG meter was present in all studies. A total
of 8/11 (72.2%) studies had mobile apps with capacity for diet
management [42-46,48,50,51]. Three studies incorporated blood
pressure function in their mobile apps [49,50,52]. There were
7/11 (63.6%) studies which had a physical activity function
[44-46,48-51] and 2/11 (18.2%) studies incorporated weight
tracking function [49,50]. There were specific functions to log
or calculate insulin dosages in mobile apps employed in the
4/11 (36.3%) studies with type 1 diabetes participants
[44-46,48]. A total of 2/11 (18.2%) studies reported a general
medication log function in their mobile apps [42,43].
With the exception of 4/11 (36.4%) studies, all others (7/11,
63.6%) had capacity for mobile apps to allow patients to analyse
logged data. These 4 studies had their logged data transferred
to a web/cloud storage and analysed by either the researcher or
the health provider [42,43,47,52].
There were 6/11 (54.5%) studies that utilised mobile apps with
an educational function. Half 3/6 (50.0%) of the studies provided
education as a personalised real-time automated educational
feedback specific to logged data [42,43,49], while the other 3
provided a general information page [44,45,51].
A total of 6/11 (54.5%) studies utilized a mobile app with a
reminder function [44,45,47,48,50,51].
Users’ Involvement
There was only 1/11 (9.1%) study [51] that clearly described
users’ involvement in the design of its mobile app. It reported
an iterative design process involving 12-15 diabetes patients
using the approach of focus group meetings, semi-structured
interviews, usability testing, questionnaires and paper
prototyping. This approach generated the design requirements
and answers to research questions [20].
Clinical Expert Involvement
There were 2/11 (18.2%) studies [42,43] which used the same
mobile app and engaged the opinions of clinical experts in the
field of diabetes during its development and design. The studies
reported that the mobile app development involved an
Endocrinologist and a Credentialed Diabetes Educator [54].
Data Security and Privacy Consideration
Report on data security and privacy varied among the studies
with limited elucidation of information in most cases. In 2/11
(18.2%) studies [42,43] the authors reported a real time
capturing of self-monitored blood glucose data into a Health
Insurance Portability and Accountability Act-compliant secured
Web-based system [54]. In 1/11 (9.1%) study, measured data
from participants were transmitted to a server. With each new
measurement the patient profile was updated allowing controlled
access to patients’ data and record history [50]. Transfer of
mobile app data into a secured central server was the only
information provided by Charpentier et al [46].
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Pilot Testing of Mobile Apps
A total of 7/11 (63.6%) studies provided information with
regards to pilot testing. Of these, 2/11 (18.2%) [42,43] reported
three months test running of the mobile app on 30 patients with
type 2 diabetes with the aim of evaluating the impact on HbA1c
and satisfaction of patients with the technology [54]. Likewise,
1/11 (9.1%) study [46] reported a 4-month open label
observational pilot study on 35 type 1 diabetic patients with the
aim of confirming if the use of the mobile app resulted in good
control of post prandial blood glucose readings [55]. Only 1/11
(9.1%) study [50] reported a one-month piloting on 11 type 2
diabetes patients to assess usability and impact of the mobile
app on HbA1c outcomes and home blood pressure monitoring
[56]. In 2/11 (18.1%) studies [44,45], 2 pilot programs were
reported through a citation in another article. The first was with
the use of a questionnaire to assess the feasibility and
acceptability of the mobile app. The second was a 9-months
follow up of 41 patients using the mobile app under routine
clinical practice condition with the aim of investigating its
effectiveness on metabolic control [57]. Lastly, 1/11 (9.1%)
study [51] reported a 12 months pilot testing on 12 persons with
type 2 diabetes [20].
Discussion
Theoretical Basis
Our review shows that most of the studies did not discuss
consideration for health behavior theories in their mobile app
development. The lack of report on theoretical basis may be as
a result of reliance on evidence-based guidelines that relates to
the essential self-care activities in people with diabetes to predict
good outcomes [58]. While it is necessary for mobile apps to
be guided by health behavioral theories, the current theories
appear incapable of answering most of the questions likely to
arise when mobile apps are employed as health interventions
[14]. Dunton and Atienza [59] reported that current health
behavior theories have not been able to incorporate
within-person differences which allow for intra-individual
tailoring of interventions. Boorsboom et al [60] noted that
between people theories do not imply, test or support causal
factors valid at the individual level. Therefore, there is a need
for more research into intra-individual non-static regulatory
models which can be incorporated in the development of mobile
technology-based health behavioral interventions.
Functionalities of Mobile Apps
All the 11 trials reviewed in this study included mobile apps
with documentation/monitoring component, where
self-documentation of blood glucose readings was the most
common. Only 3 studies used mobile apps that offer automated
direct data transfer of blood glucose values from the glucometer
or data from other measuring devices [47,50,51]. This
corroborates the report by Demidowich et al [61], where only
four of the 42 mobile apps studied offered direct data input from
glucometer. Data entry is often perceived as a persistent burden
in chronic disease management [39]. Therefore, it is imperative
that data entry in mobile apps be as spontaneous as possible,
requiring little time and effort to use [62]. Mobile app developers
should prospectively consider including an interface between
the app and biomarker measuring devices which allow users to
automatically log measurements. Such interface may include
Bluetooth which enables portable electronic devices to connect
and communicate wirelessly [63]. The success of using this
interface was demonstrated in the studies by Waki et al [50]
and Holmen et al [51].
Data analytics as an app feature was included in only 7/11
(63.3%) studies. A consumer-directed software such as mobile
app is better incorporated with functions that enable users to
enter, analyze their health parameters and view graph trends
and statistics. This can improve the patient’s ability to observe
the impact of their lifestyle and behavior on health indicators,
access trends and even predict health outcome measures [64].
Additionally, decision-making and problem-solving skills of
patients can be improved when mobile apps include visualization
techniques such as color-coded charts or graphs which indicate
when biomarkers, food carbohydrate component and physical
activity are out of recommended range [65]. It is essential that
analytic functions be dynamic, easily accessible and able to
project trends to predict individual improvement in self-care
activities which may invariably lead to better health outcomes
[66,67].
Despite the emphasis by published guidelines for the need for
ongoing patient education [7], very few studies used mobile
apps that have education as a functionality. This finding is
corroborated by another review where the authors confirmed
personalized education as an underrepresented feature in diabetes
mobile apps [23]. Patients may have difficulty consulting with
their diabetes educators or other health care professionals, due
to lack of time, financial constraints, and other limitations.
Hence, an app with an educational component can supplement
health care provider diabetes education and reinforce
information about the importance of self-management and
complication prevention. This can serve as an avenue for
continual patient empowerment to successfully deal with the
disease. However, it is essential that the personalized educational
feedback and advice provided in mobile apps are accurate. This
is especially true for those that are automatically generated
because monitoring mobile apps pose serious harm to the
patients if they fail to function as intended [68].
A total of 6/11 (54.5%) studies reported using mobile apps with
reminder function either in the form of prompting to measure
missed blood glucose readings or alerts for appointments
scheduled for the assessment of complication
[44,45,47,48,50,51]. They are sometimes referred to as ‘push
technology’; which enables messages to be delivered without
any effort on the part of the recipient [69]. Such reminders can
be in the form of text message, alarm, email, automated voice
call or image message. Other review has illustrated the benefits
of an alarm reminding patients to carry out their health activities
[70]. Another study revealed improvement in treatment
adherence as patients get fascinated using reminders to handle
their health care activities [71].
Users’ Involvement
Similar to an earlier review by El-Gayar et al [72] on the
adoption of user-centered designed principles in mobile apps,
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only one study [51] documented inquiry into users’ expectations
and perceived needs in the app developmental phase. Users’
involvement in design process increases the success rate of
computerized system usability [73], as it is essential to
understand the reasons for use and user requirements [74,75].
In contrast, a design process lacking the involvement of users
in the design loop will fail to recognize the particular odds and
problems in the use of the intervention [76]. Design processes
can use research tools such as questionnaires, focus group
discussions, and personal interviews. These help to seek users’
requirements, preferences, understand current challenges and
barriers to self-care and subsequently incorporate the findings
into the design process. Incorporation of feedback during app
design process can help in producing a more user-friendly
application and encourage long-term user engagement.
Clinical Expert Involvement
Many of the apps reported in the studies reviewed were designed
without the involvement of health care professionals, and this
observation is supported by an earlier review [77]. Involvement
of health professionals in diabetes mobile app development can
assure the quality of health information and support provided
by such apps [78]. This is especially important in mobile apps
involving advice on insulin dosing. It has to be mentioned that
the 3/11 (27.2%) studies in this review which used mobile apps
to assist participants in calculating insulin dosage failed to report
whether clinical experts were involved in the development of
these apps, even though HbA1c levels in the intervention groups
were not significantly lower compared to the control groups
[44-46]. This finding highlights possible issues with the
effectiveness, efficiency, and relevance of these mobile apps to
users’ health security. Insulin overdose in diabetics can result
to severe hypoglycemia and coma while under-dose can cause
diabetes ketoacidosis; both can have fatal consequences [79,80].
Participation of health professionals in the development of
diabetes mobile apps may decrease the likelihood of such fatal
occurrences and protect consumers from incorrect and
misleading information. Furthermore, clinical expert
involvement in diabetes mobile app development will foster
avoidance of legal implications surrounding noncompliance to
regulatory and medical standards that relate to digital health
services especially those which empower people to track,
manage and make decisions about their health [81,82].
Data Security and Privacy
Information on data security and privacy considerations in
mobile app development were lacking in many of the trials in
this review. Late consideration of privacy and security are app
developers’ errors that cannot be underestimated. Medical data
breaches resulting from failed security attract huge financial
implications (such as costs associated with a pecuniary penalty,
potential liability claim, lost brand value, responding to lawsuits,
negative press statements and essentially loss of patients’ and
health care providers’ trust) for non-compliant organizations
[82,83]. Studies have revealed that some users are concerned
about the privacy of their personal health information stored on
an electronic device [84,85]. Procedures to maintain health data
privacy and security to avoid data breaches must, therefore, be
considered during mobile app design. Encrypted storage which
ensures logged data are protected against malicious attack is a
security approach to protecting health data on mobile apps [86].
Furthermore, the privacy of users’ information can be ensured
through user authentication or enforcement of password
requirements [86], and this can protect users’ health data in case
of mobile phone loss.
Pilot Testing
There were 5/11 (45.5%) studies that failed to report on pilot
testing of their apps before use in the trial. A previous study
also reported that most health apps do not offer patients ample
opportunity for feedback on the level of satisfaction and usability
of the product [87]. The importance of pilot testing mobile apps
cannot be overemphasized. Apart from serving as an avenue
for testing the impact of the app on glycemic control pilot testing
can assess its user-friendly capacity and adherence for use as a
self-management tool.
Developmental Factors Considered in Mobile Apps
and the Key Clinical Outcome (Glycosylated
Hemoglobin)
Multimedia Appendix 2 and Multimedia Appendix 3 show an
overall evaluation of the developmental factors considered in
the design of the mobile apps used in the reviewed studies and
the resulting critical clinical outcome (ie, glycosylated
hemoglobin, HbA1c). Multimedia Appendix 3 highlighted 5/11
(45.5%) studies that had intervention groups with significantly
improved HbA1c. A comparison of these 5 studies showed that
educational functionality was present in all. For example, 3/5
(60.0%) studies provided the educational information directly
through the mobile app [43,49,50] while 2/5 (40%) provided
additional text messaging or teleconsultation [46,48]. It is likely
that the similar outcomes observed in these studies were partly
due to similitude in the provision of self-management education
to participants, as digital tools with decision support features
such as education have been proven to have the capacity to
enhance self-management outcomes [88]. This finding
demonstrates the importance of consistent and ongoing provision
of self-management education to people with diabetes. Diabetes
education and diabetes management are inseparable because
every patient would benefit from education in self-management.
Therefore, in addition to other essential functionalities in mobile
apps that support diabetes care, the inclusion of education
functionality will provide the recommended ongoing support
to promote the importance of self-management, build patient
skills, increase motivation for self-care and ultimately improve
glycemic control [89,90].
Furthermore, 3/5 (60%) studies with significant improvement
in HbA1c reported on pilot testing of their mobile apps before
use in the full trial [43,46,56]. It is possible that excellent
efficacy observed in these studies was due to pilot testing.
Among other reasons, an essential aim of pilot testing a
technology is to establish its usability. Usability testing of a
mobile app examines end users’ satisfaction and has been
identified as one of the factors that determine its efficacy and
success of users’ engagement with it. [91].
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Implication for Practice and Future Research
Much work is needed to address challenges limiting the
documentation and the implementation of developmental factors
in the design of mobile apps for diabetes management. The use
of mobile phone interventions in which the developmental
design are not explicitly documented is likely to result in a
non-replicable app with significant levels of wasted resources.
Therefore, future work is required to promote the development
of evidence-based apps research and clinical use. These mobile
apps should focus on integrating functions to core diabetes
self-management practices and primarily with the provision of
self-management education. Additionally, integrating theories
of health behavioral change, users, and clinical experts’
involvement while ensuring data privacy and security are
essential factors to be considered in the development of future
mobile apps.
Limitations of This Review
There are limitations to be considered when interpreting and
extrapolating the findings of this systematic review. The results
of this review were dependent on the terms used in the search
strategy and the efficiency of the search engines used. An
attempt to overcome this limitation was ensured by choosing
common terms and combination of terms usually used in the
literature review on mobile health apps. This review considered
only trials that were reported in the English language with strict
inclusion criteria and so the number of articles that met the study
criteria was small, and this limits the ability to generalize the
findings. Also, the process of extracting the data presented some
risk of error and uncertainty because some studies were not
explicit about their developmental considerations, and it is easy
to miss or misunderstand some development description either
reported directly within the article or referenced. However, to
avoid this occurrence, the authors ensured that the assessment
process involved independent verification and all pitfalls that
might invalidate the findings were avoided. Despite these
limitations, this review provides valuable information to future
researchers and developers of mobile apps for diabetes
management on the necessary factors to consider during app
development.
Conclusion
This systematic review has presented the crucial steps that need
to be taken in mobile app development to support effective
self-management for people with diabetes. Most of the studies
in this review offer a limited and non-expository degree of
information on the factors considered in the development of the
apps employed.
The main stakeholder in diabetes management is the patient.
Shared decision-making between diabetes patients, health care
professionals, and app developers can result in improved
management. Therefore, this should be the basis for the
development of mobile apps for diabetes support. Shared
decision-making can be achieved through the process of patient
and clinical expert involvement, ensuring data security and
privacy, pilot testing and integration of core functions that
support all aspects of diabetes self-care activities as indicated
by evidence-based guidelines. Continual integration of these
processes during app development (before actual use in clinical
trials) will ensure that specific needs of diabetic patients are
met in the finally developed app, and this will ultimately
improve diabetes support, self-management and clinical
outcomes for the patients.
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